| Dr Cheryl Ann Pfent, PSYD | |
|
790 Via Lata, Suite 250, Colton, CA 92324-3978 | |
| (909) 872-0223 | |
| (909) 872-1686 |
| Full Name | Dr Cheryl Ann Pfent |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 790 Via Lata, Colton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518003250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY18285 (California) | Primary |
| 103TC0700X | Psychologist - Clinical | PY4330 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cheryl Ann Pfent, PSYD 24813 Iceland Poppy Ct, Murrieta, CA 92563 Ph: (951) 600-7859 | Dr Cheryl Ann Pfent, PSYD 790 Via Lata, Suite 250, Colton, CA 92324-3978 Ph: (909) 872-0223 |
News Archive
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center are the first in the region to have joined a nationwide clinical trial to evaluate the effectiveness of a gene therapy in patients with advanced melanoma which is aimed to help a patient ' s own immune system fight their cancer.
The Singapore Ministry of Health has awarded Accenture, a contract to implement the National Electronic Health Record (NEHR) system, a key enabler of Singapore's vision toward a national, integrated health care system. The NEHR is designed to improve the quality of healthcare for citizens, lower the costs of health services, and promote more effective health policies.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients with ulcerative colitis.
› Verified 3 days ago
Eduardo Cabrera, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1461 E Cooley Dr Ste 100, Colton, CA 92324 Phone: 877-527-7227 | |
Miss Errinn Ann Bixby, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 900 E Washington St Ste 300, Colton, CA 92324 Phone: 989-714-3136 | |
Dr. Vanessa Francis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-1800 | |
Dr. Lelah Sharra Villalpando, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 851 S Mount Vernon Ave Ste 7a, Colton, CA 92324 Phone: 760-241-6044 Fax: 909-639-7079 | |
Rita Leigh Walker, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 450 Martin Ave, Colton, CA 92324 Phone: 909-676-9506 | |
Laura A Negin, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1461 E Cooley Dr Ste 100, Colton, CA 92324 Phone: 909-809-7337 |